VR-AI Vision Screening Platform Arrives in Britain — Affordable, Portable, and Patient-Friendly
Poole, England – 29 August 2025 – Kestrel Ophthalmics today announces the UK launch of RetinaLogik, a groundbreaking vision screening platform that utilizes VR and AI. This platform includes several exams including visual fields, colour vision, visual acuity and much more. The Retinalogik platform redefines eye care delivery through affordability, portability, and innovation, all wrapped in clinician-friendly payment models.
A Paradigm Shift in Vision Screening
Retinalogik leverages state-of-the-art virtual reality (VR) and artificial intelligence (AI) technology to deliver a comprehensive suite of eye tests, including visual field, visual acuity, colour vision, and contrast sensitivity, all via a single, lightweight VR headset. Proven in multiple peer-reviewed studies to be comparably accurate to traditional gold-standard perimetry, RetinaLogik packs patterns such as 24-2,24-2c, 10-2, 30-2, Esterman, and Full 120, along with reliability indices like false positives, false negatives, fixation loss, and gaze tracking. Additionally, they provide advanced progression analysis to track patients over time, and their platform can integrate data obtained from multiple devices to preserve your patient history.
The platform incorporates immersive tutorials, voice prompts in over 35 languages, and automated gaze feedback, features designed to engage patients and guide them intuitively through tests
By combining multiple exam workflows into one device, RetinaLogik enables faster testing, requires no dedicated clinic space, and fosters patient comfort.
Accessibility Meets Affordability
Recent reports show that Retinalogik can administer up to 85% of standard clinic eye tests in one device, while lowering clinical costs by approximately 60%, and boosting efficiency by at least 30%. Some analyses even estimate upfront capital costs may shrink by as much as 90% compared to legacy systems
Payment Models: Cost-Effective & Flexible
Kestrel Ophthalmics General Manager Christian Oster says; introducing RetinaLogik through flexible payment models that can suit every practice and makes cutting-edge VR-AI screening attainable even for smaller practices and outreach clinics, eliminating the hurdle of large capital outlays.
Regulatory Credentials & Proven Innovation
RetinaLogik has already secured Class II medical device approval from Health Canada, is ISO-13485 and MDSAP certified, and has FDA registration, setting the stage for rapid adoption and international expansion
Supporting Access and Efficiency
Dr. Abdullah Sarhan, CEO of RetinaLogik, states:
“Today we announce RetinaLogik’s launch in the UK. This is a proud moment for our organization and brings us one step toward achieving our vision of making quality vision screening accessible for everyone everywhere. We’ve developed a solution that not only makes eye care more efficient but also more affordable and accessible… this is just the beginning.”
Clinics adopting RetinaLogik enjoy not only the workflow benefits of having multiple exams on one portable piece of equipment, but improved patient engagement and broader accessibility, particularly for locations with limited resources or mobility issues.
Now Available in the UK
Starting today, UK ophthalmologists and optometrists can access RetinaLogik via Kestrel Ophthalmics. For pricing options, demonstration units, or training, contact:
Email: info@kestrelophthalmics.co.uk
Phone: +44 (0)1202 696963
